| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Review |
From the Brain Tumor Institute,* Cleveland Clinic Foundation, Cleveland, Ohio; the Women’s Cancer Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; and the Department of Neurosurgery, University of Schleswig-Holstein, Kiel, Germany
Abstract
Clinically symptomatic metastases to the central nervous system (CNS) occur in 
10 to 15% of patients with metastatic beast cancer. CNS metastases are traditionally viewed as a late complication of systemic disease, for which few effective treatment options exist. Recently, patients with Her-2-positive breast tumors who were treated with trastuzumab have been reported to develop CNS metastases at higher rates, often while responding favorably to treatment. The blood:brain barrier and the unique brain microenvironment are hypothesized to promote distinct molecular features in CNS metastases that may require tailored therapeutic approaches. New research approaches using cell lines that reliably and preferentially metastasize in vivo to the brain have been reported. Using such model systems, as well as in vitro analogs of blood-brain barrier penetration and tissue-based studies, new molecular leads into this disease are unfolding.
This article has been cited by other articles:
 |
|
 |
|
  B. Gril, D. Palmieri, J. L. Bronder, J. M. Herring, E. Vega-Valle, L. Feigenbaum, D. J. Liewehr, S. M. Steinberg, M. J. Merino, S. D. Rubin, et al. Effect of Lapatinib on the Outgrowth of Metastatic Breast Cancer Cells to the Brain J Natl Cancer Inst, August 6, 2008; 100(15): 1092 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dawood, K. Broglio, F. J. Esteva, N. K. Ibrahim, S.-W. Kau, R. Islam, K. D. Aldape, T.-K. Yu, G. N. Hortobagyi, and A. M. Gonzalez-Angulo Defining prognosis for women with breast cancer and CNS metastases by HER2 status Ann. Onc., July 1, 2008; 19(7): 1242 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-J. Stemmler and V. Heinemann Central Nervous System Metastases in HER-2-Overexpressing Metastatic Breast Cancer: A Treatment Challenge Oncologist, July 1, 2008; 13(7): 739 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Polli, J. E. Humphreys, K. A. Harmon, S. Castellino, M. J. O'Mara, K. L. Olson, L. St. John-Williams, K. M. Koch, and C. J. Serabjit-Singh The Role of Efflux and Uptake Transporters in N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, Lapatinib) Disposition and Drug Interactions Drug Metab. Dispos., April 1, 2008; 36(4): 695 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gori, S. Rimondini, V. De Angelis, M. Colozza, G. Bisagni, G. Moretti, A. Sidoni, C. Basurto, C. Aristei, P. Anastasi, et al. Central Nervous System Metastases in HER-2 Positive Metastatic Breast Cancer Patients Treated with Trastuzumab: Incidence, Survival, and Risk Factors Oncologist, July 1, 2007; 12(7): 766 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Palmieri, J. L. Bronder, J. M. Herring, T. Yoneda, R. J. Weil, A. M. Stark, R. Kurek, E. Vega-Valle, L. Feigenbaum, D. Halverson, et al. Her-2 Overexpression Increases the Metastatic Outgrowth of Breast Cancer Cells in the Brain Cancer Res., May 1, 2007; 67(9): 4190 - 4198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Aragon-Ching and J. A. Zujewski CNS Metastasis: An Old Problem in a New Guise Clin. Cancer Res., March 15, 2007; 13(6): 1644 - 1647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. U. Lin and E. P. Winer Brain Metastases: The HER2 Paradigm Clin. Cancer Res., March 15, 2007; 13(6): 1648 - 1655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. I. Chen, J. Hewel, J. S. Krueger, C. Tiraby, M. R. Weber, A. Kralli, K. Becker, J. R. Yates III, and B. Felding-Habermann Adaptation of Energy Metabolism in Breast Cancer Brain Metastases Cancer Res., February 15, 2007; 67(4): 1472 - 1486. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
